Medicine and Dentistry
Disease
100%
Neoplasm
56%
Infection
54%
Malignant Neoplasm
52%
Transplantation
50%
Overall Survival
43%
Non-Hodgkin Lymphoma
42%
Surgery
40%
Rheumatoid Arthritis
34%
Surgeon
32%
Oncology
32%
Clinical Trial
30%
COVID-19
28%
Diffuse Large B-Cell Lymphoma
27%
Radiation Therapy
27%
Diagnosis
26%
Systematic Review
24%
Liver Transplantation
23%
Health Care Cost
23%
Cancer
22%
Hodgkin's Lymphoma
22%
Symptom
20%
Pancreas Cancer
20%
Diabetes
20%
Pediatrics
20%
Drug Megadose
20%
Metastatic Carcinoma
19%
Injury
19%
Meta-Analysis
19%
Human Immunodeficiency Virus
19%
Clinician
17%
Peripheral T-Cell Lymphoma
16%
Short Bowel Syndrome
16%
Recurrent Disease
16%
Breast Cancer
15%
Mantle Cell Lymphoma
15%
Drug Therapy
15%
Non Small Cell Lung Cancer
14%
Lung Cancer
14%
Prevalence
14%
Biological Marker
14%
Biopsy
14%
Quality of Life
14%
Antibiotics
13%
Odds Ratio
13%
Adverse Event
13%
Multiple Myeloma
13%
Progression Free Survival
12%
Hazard Ratio
12%
Primary Health Care
12%
Coronary Artery Disease
12%
Apoplexy
12%
T Cell
12%
B Cell
12%
Follicular Lymphoma
11%
Rituximab
11%
Cohort Analysis
11%
Pancreas Adenocarcinoma
11%
Virus Infection
11%
Liver Graft
11%
Bladder
10%
Bone Marrow Transplantation
10%
Hematopoietic Stem Cell
10%
Rheumatology
10%
Health Care
10%
Placebo
10%
Randomized Controlled Trial
10%
Immunotherapy
10%
Targeted Therapy
10%
Abdominal Aortic Aneurysm
10%
Cardiovascular System
9%
Systemic Therapy
9%
Percutaneous Coronary Intervention
9%
Autologous Stem Cell Transplantation
9%
Combination Therapy
9%
Intestinal Transplantation
9%
Emergency Department
9%
Pathologist
9%
Outpatient
9%
Allograft
9%
Myocardial Infarction
9%
Cell Transplantation
9%
Patient Care
9%
Body Mass Index
9%
Hematopoietic Stem Cell Transplantation
9%
Oncologist
9%
Pathogen
9%
Stereotactic Body Radiation Therapy
9%
Prognostic Factor
9%
Prostate Cancer
9%
Parenteral Nutrition
9%
B-Cell Chronic Lymphocytic Leukemia
9%
Chemoradiotherapy
8%
Immunosuppressive Treatment
8%
Vitamin D
8%
Large-Cell Lymphoma
8%
Medicine
8%
Multivariate Analysis
8%
In Vitro
8%
B-Cell Lymphoma
8%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
76%
Rheumatoid Arthritis
45%
Infection
39%
Malignant Neoplasm
38%
Neoplasm
36%
Mouse
33%
Clinical Trial
30%
Chemotherapy
28%
Overall Survival
24%
Nonhodgkin Lymphoma
24%
HIV
24%
Adverse Event
21%
Placebo
19%
Inflammation
16%
Pancreas Cancer
14%
Combination Therapy
14%
Methotrexate
13%
Heart Infarction
12%
Carcinogenesis
12%
Cohort Study
12%
Biological Marker
12%
Coronary Artery Disease
12%
Remission
12%
Carcinogenicity
11%
Coronavirinae
11%
Symptom
11%
Ethanol
11%
Lung Cancer
11%
Pancreas Adenocarcinoma
11%
Randomized Controlled Trial
11%
Vitamin D
10%
Antibiotics
10%
Progression Free Survival
10%
Infectious Agent
10%
Injury
10%
Diffuse Large B Cell Lymphoma
10%
Cytokine
10%
Multiple Myeloma
10%
Prevalence
10%
Fluorocarbon
10%
Pharmacokinetics
9%
Recurrent Disease
9%
Cytotoxicity
9%
Hodgkin Disease
9%
Breast Cancer
9%
Hyperplasia
9%
Saccharin Sodium
9%
Heart Failure
8%
Peripheral Occlusive Artery Disease
8%
Disease Activity
8%
Antiinfective Agent
8%
Rituximab
8%
Cyclophosphamide
8%
Cardiovascular Disease
8%
Attention Deficit Disorder
8%
Malonaldehyde
8%
Lenalidomide
8%
Dexamethasone
8%
Comorbidity
7%
Doxorubicin
7%
Mantle Cell Lymphoma
7%
N [4 (5 Nitro 2 Furyl) 2 Thiazolyl]formamide
7%
Bladder Carcinogenesis
7%
Sepsis
7%
Antibiotic Agent
7%
SARS Coronavirus
7%
Glucose
7%
Prednisone
7%
Tumor Necrosis Factor
7%
Epidermal Growth Factor Receptor
7%
Prostate Cancer
7%
Immunotherapy
6%
Carcinogen
6%
High Dose Chemotherapy
6%
Bleeding
6%
Abdominal Aortic Aneurysm
6%
Chemoradiation Therapy
6%
Pig
6%
Dobutamine
6%
Non Small Cell Lung Cancer
6%
Disease Modifying Antirheumatic Drug
6%
Randomized Clinical Trial
6%
Survival Rate
6%
Peripheral T Cell Lymphoma
6%
Non Insulin Dependent Diabetes Mellitus
6%
Epileptic Absence
6%
Bladder Cancer
6%
Monotherapy
5%
Parkinson's Disease
5%
Tumor Necrosis Factor Inhibitor
5%
Atomoxetine
5%
Receptor
5%
Side Effect
5%
Cigarette Smoke
5%
Chronic Obstructive Lung Disease
5%
ST Segment Elevation Myocardial Infarction
5%
Mouse Model
5%
Gout
5%
Nanoparticle
5%
Ebola Virus Disease
5%
Keyphrases
NCCN Guidelines
20%
Rheumatoid Arthritis
20%
Non-Hodgkin Lymphoma
18%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Lymphoma
16%
Overall Survival
13%
Diffuse Large B-cell Lymphoma (DLBCL)
13%
Oncology
13%
Confidence Interval
12%
Clinical Practice Guidelines
12%
Chemotherapy
11%
United States
9%
Tumor
9%
Peripheral T-cell Lymphoma
9%
Clinical Trials
9%
COVID-19
8%
Transplantation
8%
Short Bowel Syndrome
8%
Relapsed or Refractory
7%
Multiple Myeloma
7%
Hodgkin Disease
6%
Pancreatic Cancer
6%
Mantle Cell Lymphoma
6%
Allogeneic Bone Marrow Transplantation
6%
Risk Factors
6%
T Cells
5%
American College of Rheumatology
5%
Bone Marrow Transplantation
5%
High-dose Chemotherapy
5%
Radiation Therapy
5%
Clinical Outcomes
5%
Ethanol
5%
Initial Treatment
5%
Nebraska
5%
High-dose Therapy
5%
Older Patients
5%
Follicular Lymphoma
5%
Peripheral Arterial Disease
5%
Non-small Cell Lung Cancer (NSCLC)
5%
High Dose
5%
Pancreatic Ductal Adenocarcinoma
5%